FDA issues recall for generic antihistamines over cross-contamination risks

The FDA has initiated a recall of specific batches of generic antihistamines due to potential cross-contamination with other pharmaceutical products. The scope of the contamination and the specific manufacturing facility involved remain under investigation, posing a risk of adverse reactions for consumers.